Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
The MedTech ConferenceThe MedTech Conference
Not Confirmed
Not Confirmed
05-08 October, 2025
The Battery ShowThe Battery Show
Not Confirmed
Not Confirmed
06-09 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
The MedTech ConferenceThe MedTech Conference
Industry Trade Show
Not Confirmed
05-08 October, 2025
The Battery ShowThe Battery Show
Industry Trade Show
Not Confirmed
06-09 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-bridge-the-gap-between-chemistry-and-performance-to-deliver-precise-optimized-micronization-for-complex-apis
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
10 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/osr-holdings-receives-nasdaq-minimum-bid-price-deficiency-notice-company-highlights-unusual-trading-activity-302551528.html
24 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/osr-holdings-enters-into-term-sheet-to-acquire-woori-io-a-pioneer-in-noninvasive-glucose-monitoring-technology-302512926.html
15 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/osr-holdings-appoints-dr-andreas-niethammer-as-chief-medical-officer-of-vaximm-ag-an-osr-company-302505105.html
09 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/darnatein-an-osr-company-broadens-intellectual-property-protection-for-innovative-osteoarthritis-treatment-technology-302424483.html
26 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/vaximm-ag-an-osr-company-announces-results-from-phase-2a-trial-of-vxm01-and-avelumab-combination-therapy-in-glioblastoma-302411928.html
22 Apr 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/osr-holdings-and-sillajen-have-entered-into-a-memorandum-of-understanding-to-collaboratively-pursue-the-development-of-innovative-therapeutics-and-enter-the-us-market-302123230.html
ABOUT THIS PAGE